The weekly litigation news digest is live. Subscribe now
Immunogenic Composition
Patent No. EP3564378 (titled "Immunogenic Composition") was filed by Glaxosmithkline on May 25, 2012. The application was issued on Nov 1, 2023.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3564378
- Application Number
- EP19179871A
- Filing Date
- May 25, 2012
- Status
- Revoked
- Mar 21, 2025
- Publication Date
- Nov 1, 2023
- External Links
- Slate, EP3564378B1, Google Patents